[1 Prignano F, Ortonne JP, Buggiani G, Lotti T. Therapeutical approaches in melasma. Dermatol Clin. 2007;25(3):337–42.10.1016/j.det.2007.04.006]Search in Google Scholar
[2. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55(6):1048–65.10.1016/j.jaad.2006.02.009]Search in Google Scholar
[3. Katsambas AD, Stratigos AJ, Lotti TM. Melasma. In: Katsambas AD, Lotti TM, editors. European handbook of dermatological treatments. 2nd ed. Berlin: Springer; 2003. p. 336.10.1007/978-3-662-07131-1_59]Search in Google Scholar
[4. Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65(4):689–97.10.1016/j.jaad.2010.12.046]Search in Google Scholar
[5. Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46(2):111–6.10.1016/j.jdermsci.2007.01.009]Search in Google Scholar
[6. Elling SV, Powell FC. Physiological changes in the skin during pregnancy. Clin Dermatol. 1997;15(1):35–43.10.1016/S0738-081X(96)00108-3]Search in Google Scholar
[7. Ejaz A, Raza N, Iftikhar N, Muzzafar F. Comparison of 30% salicylic acid with Jessner’s solution for superficial chemical peeling in epidermal melasma. J Coll Physicians Surg Pak. 2008;18(4):205–8.]Search in Google Scholar
[8. Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, et al. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg. 2006;32(5)-:626–31.10.1111/j.1524-4725.2006.32133.x16706756]Search in Google Scholar
[9. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57 (6):-1005–32.10.2165/00003495-199957060-0001710400410]Search in Google Scholar
[10. Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol. 1994;130(6):727–33.10.1001/archderm.1994.01690060057005]Search in Google Scholar
[11. Nijor T. Treatment of melasma with tranexamic acid. J Clin Res. 1979;13:3129–31.]Search in Google Scholar
[12. Leminen H, Hurskainen R. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012;4:413–21.]Search in Google Scholar
[13. Del Rosario E, Florez-Pollack S, Zapata L Jr, Hernandez K, Tovar-Garza A, Rodrigues M, et al. Randomized placebo controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. J Am Acad Dermatol. 2017;78(2):363–9.10.1016/j.jaad.2017.09.05328987494]Search in Google Scholar
[14. Lajevardi V, Ghayoumi A, Abedini R, Hosseini H, Goodarzi A, Akbari Z, et al. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor and analyst-blinded, randomized controlled trial with a short-term follow-up. J Cosmet Dermatol. 2017;16(2):235–42.10.1111/jocd.1229127762489]Search in Google Scholar
[15. Cho HH, Choi M, Cho S, Lee JH. Role of tranexamic acid in melasma patients treated with IPL and low fluence QS Nd: YAG laser. J Dermatol Treat. 2013;24-(4):292–6.10.3109/09546634.2011.64322022103770]Search in Google Scholar
[16. Karn D, Kc S, Amatya A, Razouria EA, Timalsina M. Oral tranexamic acid for the treatment of melasma. Kathmandu Univ Med J (KUMJ). 2012;10(40):40–3.]Search in Google Scholar
[17. Kato H, Araki J, Eto H, Doi K, Hirai R, Kuno S, et al. A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyper-pigmentation after Q-switched ruby laser. Dermatol Surg. 2011;37(5):605–10.10.1111/j.1524-4725.2011.01957.x21457392]Search in Google Scholar
[18. Sharma R, Mahajan VK, Mehta KS, Chauhan PS, Rawat R, Shiny TN. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clin Exp Dermatol. 2017;42(7):721–34.10.1111/ced.1316428649780]Search in Google Scholar
[19. Wu S, Shi H, Wu H, Yan S, Guo J, Sun Y, et al. Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg. 2012;36(4):964–70.10.1007/s00266-012-9899-922552446]Search in Google Scholar
[20. Lee HC, Thng TG, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75(2):385–92.10.1016/j.jaad.2016.03.00127206758]Search in Google Scholar
[21. Tan AWM, Sen P, Chua SH, Goh BK. Oral tranexamic acid lightens refractory melasma. Australas J Dermatol. 2017;58(3):e105–8.10.1111/ajd.1247427173008]Search in Google Scholar
[22. Shin JU, Park J, Oh SH, Lee JH. Oral tranexamic acid enhances the efficacy of low-fluence 1040-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized prospective trial. Dermatol Surg. 2013;39(3 Pt 1):435–42.10.1111/dsu.1206023278870]Search in Google Scholar
[23. Padhi T, Pradhan S. Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: an open labeled randomized comparative trial. Indian J Dermatol. 2015;60(5):520.10.4103/0019-5154.164416460144026538719]Search in Google Scholar